Management of vitreous floaters: a review.

IF 3 2区 医学 Q1 OPHTHALMOLOGY Current Opinion in Ophthalmology Pub Date : 2024-09-01 Epub Date: 2024-07-11 DOI:10.1097/ICU.0000000000001075
Alexis Ivan Aleman, Lauren Kiryakoza, Jayanth Sridhar, Jesse Sengillo
{"title":"Management of vitreous floaters: a review.","authors":"Alexis Ivan Aleman, Lauren Kiryakoza, Jayanth Sridhar, Jesse Sengillo","doi":"10.1097/ICU.0000000000001075","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Vitreous floaters, characterized by the perception of spots or shadows in the visual field, commonly result from posterior vitreous detachment and can cause chronic symptoms in affected patients. The diagnosis of posterior vitreous detachment is typically determined clinically and can sometimes be confirmed with optical coherence topography (OCT) [1 ▪▪ ] . The objective of this review is to review management options for symptomatic vitreous floaters.</p><p><strong>Recent findings: </strong>Symptoms of vitreous floaters may be mild or may significantly affect patient quality of life. Observation is the most common management strategy. Procedural management options include pars plana vitrectomy (PPV) and neodymium-doped yttrium aluminium garnet (Nd:YAG) vitreolysis. PPV is considered the most definitive management option for vitreous floaters. PPV, however, carries inherent risks, notably infection, cataract formation, and retinal detachment [2] . Nd:YAG laser vitreolysis is a less invasive alternative with studies demonstrating varied success [1 ▪▪ ,3,4] .</p><p><strong>Summary: </strong>This review provides insights into the current state of knowledge regarding the management of vitreous floaters and can guide clinical decision-making.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ICU.0000000000001075","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: Vitreous floaters, characterized by the perception of spots or shadows in the visual field, commonly result from posterior vitreous detachment and can cause chronic symptoms in affected patients. The diagnosis of posterior vitreous detachment is typically determined clinically and can sometimes be confirmed with optical coherence topography (OCT) [1 ▪▪ ] . The objective of this review is to review management options for symptomatic vitreous floaters.

Recent findings: Symptoms of vitreous floaters may be mild or may significantly affect patient quality of life. Observation is the most common management strategy. Procedural management options include pars plana vitrectomy (PPV) and neodymium-doped yttrium aluminium garnet (Nd:YAG) vitreolysis. PPV is considered the most definitive management option for vitreous floaters. PPV, however, carries inherent risks, notably infection, cataract formation, and retinal detachment [2] . Nd:YAG laser vitreolysis is a less invasive alternative with studies demonstrating varied success [1 ▪▪ ,3,4] .

Summary: This review provides insights into the current state of knowledge regarding the management of vitreous floaters and can guide clinical decision-making.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
玻璃体漂浮物的处理:综述。
综述的目的:玻璃体漂浮物的特征是视野中出现斑点或阴影,常见于玻璃体后脱离,可导致患者出现慢性症状。玻璃体后脱离的诊断通常由临床确定,有时可通过光学相干地形图(OCT)确诊[1▪▪]。本综述旨在回顾无症状玻璃体漂浮物的治疗方案:玻璃体漂浮物的症状可能很轻微,也可能严重影响患者的生活质量。观察是最常见的治疗策略。手术治疗方案包括玻璃体旁切除术(PPV)和掺钕钇铝石榴石(Nd:YAG)玻璃体溶解术。PPV被认为是玻璃体漂浮物最彻底的治疗方案。然而,PPV 也存在固有的风险,尤其是感染、白内障形成和视网膜脱离[2]。Nd:YAG 激光玻璃体溶解术是一种创伤较小的替代方法,研究显示其成功率不尽相同[1▪▪,3,4]。摘要:本综述深入介绍了有关玻璃体漂浮物治疗的知识现状,可为临床决策提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.80
自引率
5.40%
发文量
120
审稿时长
6-12 weeks
期刊介绍: Current Opinion in Ophthalmology is an indispensable resource featuring key up-to-date and important advances in the field from around the world. With renowned guest editors for each section, every bimonthly issue of Current Opinion in Ophthalmology delivers a fresh insight into topics such as glaucoma, refractive surgery and corneal and external disorders. With ten sections in total, the journal provides a convenient and thorough review of the field and will be of interest to researchers, clinicians and other healthcare professionals alike.
期刊最新文献
Ocular toxicities associated with antibody drug conjugates. Ocular manifestations of juvenile Sjögren's disease. Immune recovery uveitis: an ocular manifestation in HIV/AIDS receiving treatment. Ocular involvement in Steven-Johnson syndrome/toxic epidermal necrolysis: recent insights into pathophysiology, biomarkers, and therapeutic strategies. Artificial intelligence applications in ophthalmic surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1